DCP (Des-Gamma-Carboxy-Prothrombin)

The DCP (Des-Gamma-Carboxy-Prothrombin) test contains 1 test with 1 biomarker.

The DCP assay is intended for in vitro diagnostic use as an aid in the risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma (HCC) in conjunction with other laboratory findings and clinical assessment.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: DCP DesGammaCarboxyProthrombin, Des-gamma-carboxy prothrombin (DCP), PIVKA II (protein induced by vitamin K absence or antagonists II)

Dcp (Des Gamma Carboxy

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.